Use of aripiprazole in adolescents with a history of lupus-associated psychosis and refractory psychiatric manifestations

Journal of Psychiatric Practice

Volumn 17, Issue 3, 2011, Pages 212-216

  Muscal, Eyal ^a   Bang, Leng ^a   Mian, Ayesha ^a   Harris, Toi Blakley ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

aripiprazole; atypical antipsychotic; neuropsychiatric lupus; psychosis; systemic lupus erythematosus

Indexed keywords

ARIPIPRAZOLE; ATORVASTATIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; LORAZEPAM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; QUETIAPINE; RISPERIDONE;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AKATHISIA; ANAMNESIS; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; DELIRIUM; DISEASE ASSOCIATION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSLIPIDEMIA; DYSTONIA; EVENING DOSAGE; FEMALE; HEMODIALYSIS; HUMAN; INSOMNIA; IRRITABILITY; KIDNEY FAILURE; LOW DRUG DOSE; METABOLIC DISORDER; MORNING DOSAGE; NEPHRITIS; PLEOCYTOSIS; PSYCHOSIS; SEDATION; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; WEIGHT GAIN;

ADOLESCENT; ADRENAL CORTEX HORMONES; ANTIPSYCHOTIC AGENTS; DYSLIPIDEMIAS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; NEUROPSYCHOLOGICAL TESTS; PIPERAZINES; PSYCHOTIC DISORDERS; QUINOLONES; REMISSION INDUCTION; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 79958048616     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000398416.89986.c3     Document Type: Article

References (24)

1. Lehman T. Systemic lupus erythematosus in childhood and adolescence. In: Wallace DJ, ed. Dubois' lupus erythematosus, Volume 6. Philadelphia, PA: Lippincott Williams & Wilkins: 2002:864-84.
2. Hahn BH. Antibodies to DNA. N Engl J Med 1998;338: 1359-68. (Pubitemid 28216666)
3. Viorritto IC, Nikolov NP, Siegel RM. Autoimmunity versus tolerance: Can dying cells tip the balance? Clin Immunol 2007;122:125-34. (Pubitemid 46073889)
4. Ronnblom L, Pascual V. The innate immune system in SLE: Type I interferons and dendritic cells. Lupus 2008;17:394-9. (Pubitemid 351798715)
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997;40:1725.
6. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
7. Brey RL. Neuropsychiatric lupus: Clinical and imaging aspects. Bull NYU Hosp Jt Dis 2007;65:194-9. (Pubitemid 351412132)
8. Bodani M, Kopelman MD. A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus. Lupus 2003;12:947-9. (Pubitemid 38082092)
9. Sakic B, Lacosta S, Denburg JA, et al. Altered neurotransmission in brains of autoimmune mice: Pharmacological and neurochemical evidence. J Neuroimmunol 2002;129: 84-96. (Pubitemid 34874913)
10. Pinto JP, Morais SL, Hallak JE, et al. Effectiveness of olanzapine for systemic lupus erythematosus-related psychosis. Prim Care Companion J Clin Psychiatry 2006;8: 377-8. (Pubitemid 44968946)
11. Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 2009;124:1533-40.
12. Strawn JR, Delgado SV. Successful treatment of catatonia with aripiprazole in an adolescent with psychosis. J Child Adolesc Psychopharmacol 2007;17:733-5. (Pubitemid 350058979)
13. Haupt DW, Fahnestock PA, Flavin KA, et al. Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients. Neuropsychopharmacology 2007;32:2561-9. (Pubitemid 350126844)
14. Correll CU, Manu P, Olshanskiy V, et al. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009;302: 1765-73.
15. Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review. CNS Drugs 2005;19(suppl 1):1-93. (Pubitemid 40677047)
16. Hanly JG. Neuropsychiatric lupus. Curr Rheumatol Rep 2001;3:205-12.
17. Kowal C, Degiorgio LA, Lee JY, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006;103:19854-9. (Pubitemid 46037520)
18. Katzav A, Solodeev I, Brodsky O, et al. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis Rheum 2007;56:938-48. (Pubitemid 46399441)
19. Appenzeller S, Cendes F, Costallat LT. Acute psychosis in systemic lupus erythematosus. Rheumatol Int 2008;28: 237-43. (Pubitemid 350265464)
20. Kato O, Misawa H. Steroid-induced psychosis treated with valproic acid and risperidone in a patient with systemic lupus erythematosus. Prim Care Companion J Clin Psychiatry 2005;7:312.
21. Nishimura K, Omori M, Horikawa N, et al. Risperidone in the treatment of acute confusional state (delirium) due to neuropsychiatric lupus erythematosus: Case report. Int J Psychiatry Med 2003;33:299-303. (Pubitemid 38351954)
22. Sibbitt WL, Jr., Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002;29:1536-42. (Pubitemid 34755624)
23. Muscal E, Nadeem T, Li X, et al. Evaluation and treatment of acute psychosis in children with systemic lupus erythematosus (SLE): Consult-liaison service experiences at a tertiary care pediatric institution. Psychosomatics 2010;51:508-14.
24. Turkel SB, Miller JH, Reiff A. Case series: Neuropsychiatric symptoms with pediatric systemic lupus erythematosus. J Am Acad Child Adolesc Psychiatry 2001;40:482-5. (Pubitemid 32243486)